Charles Schwab Investment Management Inc Pacira Bio Sciences, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 414,151 shares of PCRX stock, worth $9.42 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
414,151
Previous 371,666
11.43%
Holding current value
$9.42 Million
Previous $12.5 Million
3.5%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding PCRX
# of Institutions
287Shares Held
48.7MCall Options Held
156KPut Options Held
623K-
Black Rock Inc. New York, NY7.91MShares$180 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$116 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.91MShares$43.5 Million0.55% of portfolio
-
State Street Corp Boston, MA1.9MShares$43.3 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.88MShares$42.8 Million0.09% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.04B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...